Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM.
Here's what investors need to know about the announcement.
Earnings
Matinas BioPharma Hldgs missed estimated earnings by 50.0%, reporting an EPS of $-0.03 versus an estimate of $-0.02.
Revenue was down $33.33 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 7.04% increase in the share price the next day.
Here's a look at Matinas BioPharma Hldgs's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.02 | -0.03 | -0.03 |
| EPS Actual | -0.03 | -0.03 | -0.02 | -0.03 |
| Revenue Estimate | 470.00K | 1.53M | 30.00K | 20.00K |
| Revenue Actual | 0 | 0 | 0 | 33.33K |
To track all earnings releases for Matinas BioPharma Hldgs visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
